Unresectable Gastric Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-12-31
Clinical Trial Update: First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) [Phase 2]
Phase 2 study of RC48 plus sintilimab and S-1 as first-line therapy for advanced gastric cancer, including HER2-positive, metastatic, and un…